SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

Saved in:
Bibliographic Details
Main Authors SUN SHAOYI, SUN JIANYU, WOOD MARK, LANGILLE JONATHAN, JIA QI, GAUTHIER SIMON J, CHAKKA NAGASREE, CHOWDHURY SULTAN, DOUGLAS AMY FRANCES, CIKOJEVIC ZORAN, FU JIANMIN, LIU SHIFENG, SVIRIDOV SERGUEI, CADIEUX JEAN-JACQUES ALEXANDRE, FRASER LAUREN, CHAFEEV MIKHAIL, ZENOVA ALLA YUREVNA, HSIEH TOM
Format Patent
LanguageEnglish
Published 15.10.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
AbstractList This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Author CHAKKA NAGASREE
CHOWDHURY SULTAN
SUN SHAOYI
CIKOJEVIC ZORAN
GAUTHIER SIMON J
SUN JIANYU
LANGILLE JONATHAN
FRASER LAUREN
ZENOVA ALLA YUREVNA
SVIRIDOV SERGUEI
LIU SHIFENG
CHAFEEV MIKHAIL
WOOD MARK
CADIEUX JEAN-JACQUES ALEXANDRE
DOUGLAS AMY FRANCES
FU JIANMIN
JIA QI
HSIEH TOM
Author_xml – fullname: SUN SHAOYI
– fullname: SUN JIANYU
– fullname: WOOD MARK
– fullname: LANGILLE JONATHAN
– fullname: JIA QI
– fullname: GAUTHIER SIMON J
– fullname: CHAKKA NAGASREE
– fullname: CHOWDHURY SULTAN
– fullname: DOUGLAS AMY FRANCES
– fullname: CIKOJEVIC ZORAN
– fullname: FU JIANMIN
– fullname: LIU SHIFENG
– fullname: SVIRIDOV SERGUEI
– fullname: CADIEUX JEAN-JACQUES ALEXANDRE
– fullname: FRASER LAUREN
– fullname: CHAFEEV MIKHAIL
– fullname: ZENOVA ALLA YUREVNA
– fullname: HSIEH TOM
BookMark eNrjYmDJy89L5WSwCQ7wDPLX9Y_w9HPx93FVcPb3DfAP9XMJVnD0c1EI8XD1DFIIDXZVcAwGcYIcA1xDQzydFRzdXf1CgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoamRpaGZkbGjoTFxqgDQsCxX
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2015291623A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2015291623A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2015291623A13
Notes Application Number: US201414542367
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151015&DB=EPODOC&CC=US&NR=2015291623A1
ParticipantIDs epo_espacenet_US2015291623A1
PublicationCentury 2000
PublicationDate 20151015
PublicationDateYYYYMMDD 2015-10-15
PublicationDate_xml – month: 10
  year: 2015
  text: 20151015
  day: 15
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies XENON PHARMACEUTICALS INC
RelatedCompanies_xml – name: XENON PHARMACEUTICALS INC
Score 3.004331
Snippet This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151015&DB=EPODOC&locale=&CC=US&NR=2015291623A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DeditMpAaVvRbq2cwWHdEnmKq4pTSt7G23XgCDdcBX_vte66Z72lstBuEtyX0nuAnBnKaWspD_XM_TGdQtXWU97c1tPjdywM0s5v1n8E783jq2XqT1twMcmF6auE_pdF0dEicpQ3staXy__D7FY_bZydZ--Y9fiaRQNmLaOjo1qh9kaGw54IJigGqWDWGp-WOO66Ap1TRdjpT10pB8qeeBvwyovZbltVEbHsB_geEV5Ao28aMEh3fy91oKDyfrKG5tr6VudwqMMvFDoYur5TLxyQsUkELHPJHF9RqIx90ISS05cWQGhG_A48ihxn7kfyTO4HfGIjnUkY_bH9SyW2zSb59AsFkV-AQR5nJtJ5ijTMC2VdRPlJH107Hp53zFyU7Whs2uky93oKziqwEo9G3YHmuXnV36NdrdMb-rp-gEJLYB9
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhTnG86FadTA0rfinRt5woO6ZLMVtek9EP2NtquAUG64Sr-fdO66Z72luTguEtyX0nuAnBnCCGMZDBXM-mNq4ZcZTXtz0011XLNzAxh_Wbxe6zvxMbL1Jw24GOTC1PXCf2uiyNKicqkvJe1vl7-H2KR-m3l6j59l0OLp3E0JMo6OtaqHWYqZDSkPiccKxgP41BhQQ3rSVeop9syVtqTTvZDJQ_0bVTlpSy3jcr4CPZ9ia8oj6GRF21o4c3fa2048NZX3rK5lr7VCTyGvhtwlU9dRviEIsw9n8eMhMhmBEUOdQMUhxTZYdUJbJ_GkYuR_UxZFJ7C7ZhG2FElGbM_rmdxuE2zfgbNYlHk54Akj3M9ySyha7ohsl4irGQgHbt-PrC0XBcd6O7CdLEbfAMtJ_Ims4nLXi_hsAJVqlozu9AsP7_yK2mDy_S6nrofO6SDcA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SPIRO-OXINDOLE+COMPOUNDS+AND+THEIR+USE+AS+THERAPEUTIC+AGENTS&rft.inventor=SUN+SHAOYI&rft.inventor=SUN+JIANYU&rft.inventor=WOOD+MARK&rft.inventor=LANGILLE+JONATHAN&rft.inventor=JIA+QI&rft.inventor=GAUTHIER+SIMON+J&rft.inventor=CHAKKA+NAGASREE&rft.inventor=CHOWDHURY+SULTAN&rft.inventor=DOUGLAS+AMY+FRANCES&rft.inventor=CIKOJEVIC+ZORAN&rft.inventor=FU+JIANMIN&rft.inventor=LIU+SHIFENG&rft.inventor=SVIRIDOV+SERGUEI&rft.inventor=CADIEUX+JEAN-JACQUES+ALEXANDRE&rft.inventor=FRASER+LAUREN&rft.inventor=CHAFEEV+MIKHAIL&rft.inventor=ZENOVA+ALLA+YUREVNA&rft.inventor=HSIEH+TOM&rft.date=2015-10-15&rft.externalDBID=A1&rft.externalDocID=US2015291623A1